Search - tctmd.com

Displaying 41 - 60 of 10207

Sort: Relevancy | Date

Presentation THT 2026

Treatment patterns among mixed phenotype transthyretin amyloidosis patients: A real-world multinational survey

Presenter: Mia Papas

March 03, 2026

Presentation THT 2026

Development of Cardiomyopathy in Patients with ADHD Treated with Stimulants, Nonstimulants, and No Pharmacotherapy

Presenter: Matthew Ramm

March 03, 2026

Presentation THT 2026

Early Human Feasibility Experience with a Novel Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation in Heart Failure reduced Ejection Fraction

Presenter: Edwin Ho

March 03, 2026

Presentation THT 2026

Automated 99mTechnetium-Pyrophosphate Planar Scintigraphy Interpretation From Clinical Imaging PDFs Using a Vision-Enabled Reasoning Large Language Models

Presenter: Akshay Arora

March 03, 2026

Presentation THT 2026

Characteristics associated with disease progression in patients with transthyretin amyloid cardiomyopathy treated with tafamidis

Presenter: Hanna Gaggin

March 03, 2026

Presentation THT 2026

Real-World Outcomes of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

Central Venous Congestion in Transcatheter Tricuspid Repair: Lessons from the TRI.Fr Trial

Presenter: Karl-Philipp Rommel

March 03, 2026

Presentation THT 2026

Predictors of Structural Remodeling After TAVR in Moderate Aortic Stenosis with Heart Failure with Reduced Ejection Fraction

Presenter: Afek Kodesh

March 03, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2026

Michael O'Riordan

March 02, 2026

Presentation THT Abstracts 2026

Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Cardiogenic Shock

Presenter: Omaima Chaudhary

March 02, 2026

Presentation THT Abstracts 2026

Rethinking Rheumatic Mitral Stenosis: Repeat Percutaneous Mitral Valve Repair as a Viable Option

Presenter: Ezra Schneier

March 02, 2026

Presentation THT Abstracts 2026

Sex-Based Differences on Clinical Outcomes After Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis

Presenter: Mark Darkwah

March 02, 2026

Presentation THT Abstracts 2026

Successful ViV-TAVR on a Deteriorated Mosaic Bioprosthetic Valve: A Promising Alternative to High-Risk Surgical Repair

Presenter: Rani Marhaba

March 02, 2026

News Daily News

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

Yael L. Maxwell

February 26, 2026

News Conference News EAPCI 2026

AVR in Asymptomatic AS: Look to the ‘Sweet Spot’ for Timing

Caitlin E. Cox

February 25, 2026

News Features

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Michael O'Riordan

February 24, 2026

News Conference News THT 2026

THT 2026: What to Expect in Boston

Todd Neale

February 23, 2026

News Conference News EAPCI 2026

AI in Cardiovascular Imaging and Interventions: Boon or Bane?

Caitlin E. Cox

February 20, 2026

News Daily News

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Michael O'Riordan

February 19, 2026

Advertisement

Treatment patterns among mixed phenotype transthyretin amyloidosis patients: A real-world multinational survey

Development of Cardiomyopathy in Patients with ADHD Treated with Stimulants, Nonstimulants, and No Pharmacotherapy

Early Human Feasibility Experience with a Novel Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation in Heart Failure reduced Ejection Fraction

Automated 99mTechnetium-Pyrophosphate Planar Scintigraphy Interpretation From Clinical Imaging PDFs Using a Vision-Enabled Reasoning Large Language Models

Characteristics associated with disease progression in patients with transthyretin amyloid cardiomyopathy treated with tafamidis

Real-World Outcomes of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Central Venous Congestion in Transcatheter Tricuspid Repair: Lessons from the TRI.Fr Trial

Predictors of Structural Remodeling After TAVR in Moderate Aortic Stenosis with Heart Failure with Reduced Ejection Fraction

TCTMD’s Top 10 Most Popular Stories for February 2026

Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Cardiogenic Shock

Rethinking Rheumatic Mitral Stenosis: Repeat Percutaneous Mitral Valve Repair as a Viable Option

Sex-Based Differences on Clinical Outcomes After Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis

Successful ViV-TAVR on a Deteriorated Mosaic Bioprosthetic Valve: A Promising Alternative to High-Risk Surgical Repair

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

AVR in Asymptomatic AS: Look to the ‘Sweet Spot’ for Timing

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

THT 2026: What to Expect in Boston

AI in Cardiovascular Imaging and Interventions: Boon or Bane?

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content